LI Jin-yin, JIA Rong-fei, JIANG Ling, et al. Ibrutinib in treatment of mantle cell lymphoma with IGHV non-mutated and bone marrow metastatic: report of two cases[J]. Chin J Clin Med, 2021, 28(6): 1086-1091. DOI: 10.12025/j.issn.1008-6358.2021.20210825
|
Citation:
|
LI Jin-yin, JIA Rong-fei, JIANG Ling, et al. Ibrutinib in treatment of mantle cell lymphoma with IGHV non-mutated and bone marrow metastatic: report of two cases[J]. Chin J Clin Med, 2021, 28(6): 1086-1091. DOI: 10.12025/j.issn.1008-6358.2021.20210825
|
LI Jin-yin, JIA Rong-fei, JIANG Ling, et al. Ibrutinib in treatment of mantle cell lymphoma with IGHV non-mutated and bone marrow metastatic: report of two cases[J]. Chin J Clin Med, 2021, 28(6): 1086-1091. DOI: 10.12025/j.issn.1008-6358.2021.20210825
|
Citation:
|
LI Jin-yin, JIA Rong-fei, JIANG Ling, et al. Ibrutinib in treatment of mantle cell lymphoma with IGHV non-mutated and bone marrow metastatic: report of two cases[J]. Chin J Clin Med, 2021, 28(6): 1086-1091. DOI: 10.12025/j.issn.1008-6358.2021.20210825
|
DownLoad: